Solution
Industries
Resources
About

FUJIFILM Biotechnologies

Company Snapshot

Founded: 2011
Entity Type: Private
Employees: 5,000
Region: Japan
Headquarter: Tokyo, Japan
Key Geographics: North America, Europe, Asia-Pacific
Corporate Address: R7 Building, 7-12-2 Roppongi, Minato-ku, Tokyo 106-0032, Japan Tel.: +81-36871-7736 Web.: www.fujifilmbiotechnologies.fujifilm.com

Company Overview

Fujifilm Diosynth Biotechnologies (Diosynth) is a biopharmaceutical contract manufacturing company. It collaborates with biopharmaceutical and biotech companies to advance the development and manufacturing of advanced biologics, therapies, and vaccines. It creates manufacturing procedures, produces active ingredients, and offers pharmaceutical companies fill and finish services. The company has facilities in the U.S., U.K., Denmark, and Japan.

FUJIFILM Biotechnologies In Reports

Global Viral Vector Manufacturing Markets and Technologies Through 2030

According to BCC Research detailed report on the viral vector manufacturing market data will be provided for 2024 because of the base year, with forecasts for 2025 and forecast value for 2030.

Global Market Opportunities and Competitive Landscape for CDMO

BCC Research Report: Dive into the contract development and manufacturing organization (CDMO) market analyzed to determine present and future market status, as well as forecasted growth from 2024 to 2029.

Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets

BCC Research Market Report says global market for biologics CDMOs is expected to increase from $15.1 billion in 2023 to $27.0 billion by the end of 2028, with a CAGR of 12.3%.

View All Reports

FUJIFILM Biotechnologies In News

Lessons Learned on Commercializing an Allogeneic T Cell Therapy - Fierce Biotech

Fierce Biotech - Aug 19, 2026

Maja Pedersen named president, taking reins of Fujifilm's CDMO as CEO role is retired - Fierce Pharma

Fierce Pharma - Aug 06, 2026

FUJIFILM Biotechnologies Transitions Leadership - Contract Pharma

Contract Pharma - Aug 04, 2026

$3B manufacturing site scales up in Wake County - The Business Journals

The Business Journals - Jul 21, 2026

Read All News

Company's Business Segments

  • Biopharmaceutical Products and Services : The company offers services for the development and manufacturing of biopharmaceuticals, vaccines, and advanced therapies.

Applications/End User Industries

  • Biopharmaceutical
  • Healthcare
  • Life Sciences
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment